Dxu Iris
Payments companies reported to CMS as associated with Dxu Iris. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Dxu Iris, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Dxu Iris
These are the largest totals companies reported as associated with Dxu Iris. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Harris Goodman | Oakland, CA | Anatomic Pathology & Clinical Pathology | $164.22 |
| Rafael Nivar-Aristy | Marion, OH | Clinical Pathology/Laboratory Medicine | $59.98 |
| Stephen Mastorides | Tampa, FL | Molecular Genetic Pathology (Pathology) | $57.52 |
| David Nash | Salem, OH | Anatomic Pathology & Clinical Pathology | $32.81 |
| Amanda Haynes | Danville, PA | Anatomic Pathology & Clinical Pathology | $26.27 |
| Juan Suriel | Glen Burnie, MD | Anatomic Pathology & Clinical Pathology | $16.15 |
| Kenneth Muldrew | Jackson, MS | Clinical Pathology | $14.29 |
| Gordana Verstovsek | Houston, TX | Cytopathology | $14.29 |
| Michael Ittmann | Houston, TX | Anatomic Pathology | $14.29 |
| Linda Green | Houston, TX | Cytopathology | $14.29 |
Prescribed Dxu Iris?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.